Cervical, Vulvar and Vaginal Cancers
|
Cancer Type |
Protocol Title | Protocol Title | ClinicalTrials.Gov Link |
Eligibility Criteria |
Study Contact |
|---|---|---|---|---|---|
| Recurrent | Xencor | A Phase 2 Study of XmAb®20717 in Patients With Selected Gynecological Malignancies and High-Risk Metastatic Castration-Resistant Prostate Cancer | NCT05032040 | Eligibility Criteria | Isabel Forbes |